Cabaletta Bio, Inc.
NASDAQ:CABA
4 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|---|
Assets: | |||||||
Current Assets: | |||||||
Cash & Cash Equivalents
| 193.238 | 81.607 | 122.222 | 101.429 | 136.204 | 33.017 | 0.001 |
Short Term Investments
| 48.011 | 24.94 | 0 | 7.233 | 0 | 0 | 0 |
Cash and Short Term Investments
| 241.249 | 106.547 | 122.222 | 108.662 | 136.204 | 33.017 | 0.001 |
Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 3.241 | 2.287 | 2.319 | 4.873 | 4.348 | 0.977 | 0 |
Total Current Assets
| 244.49 | 108.834 | 124.541 | 113.535 | 140.552 | 33.994 | 0.001 |
Non-Current Assets: | |||||||
Property, Plant & Equipment, Net
| 7.451 | 7.569 | 1.438 | 0.89 | 0.815 | 0 | 0 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 1.709 | 0.565 | 0.357 | 0.299 | 0.101 | 0.18 | 0 |
Total Non-Current Assets
| 9.16 | 8.134 | 1.795 | 1.189 | 0.916 | 0.18 | 0 |
Total Assets
| 253.65 | 116.968 | 126.336 | 114.724 | 141.468 | 34.174 | 0.001 |
Liabilities & Equity: | |||||||
Current Liabilities: | |||||||
Account Payables
| 4.547 | 2.463 | 2.333 | 1.243 | 0.92 | 0.603 | 0.189 |
Short Term Debt
| 3.56 | 2.179 | 0 | 0 | 0 | 0 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities
| 7.887 | 4.847 | 6.047 | 3.937 | 2.227 | 0.34 | 0.061 |
Total Current Liabilities
| 15.994 | 9.489 | 8.38 | 5.18 | 3.147 | 0.943 | 0.25 |
Non-Current Liabilities: | |||||||
Long Term Debt
| 1.458 | 2.959 | 0 | 0 | 0 | 43.921 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Non-Current Liabilities
| 1.458 | 2.959 | 0 | 0 | 0 | 43.921 | 0.189 |
Total Liabilities
| 17.452 | 12.448 | 8.38 | 5.18 | 3.147 | 44.864 | 0.25 |
Equity: | |||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 141.468 | 43.921 | 0 |
Common Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Retained Earnings
| -233.237 | -165.562 | -112.587 | -66.298 | -32.959 | -12.452 | -0.25 |
Accumulated Other Comprehensive Income/Loss
| 0.039 | -0.047 | 0 | 0.006 | 0 | 0 | 0 |
Other Total Stockholders Equity
| 469.396 | 270.129 | 230.543 | 175.836 | 29.812 | -42.159 | 0.001 |
Total Shareholders Equity
| 236.198 | 104.52 | 117.956 | 109.544 | 138.321 | -10.69 | -0.249 |
Total Equity
| 236.198 | 104.52 | 117.956 | 109.544 | 138.321 | -10.69 | -0.249 |
Total Liabilities & Shareholders Equity
| 253.65 | 116.968 | 126.336 | 114.724 | 141.468 | 34.174 | 0.001 |